Who founded CV Therapeutics?

CV Therapeutics was founded by Lou Lange, Michael L. Riordan.

Who are CV Therapeutics's investors?

CV Therapeutics's investors include Aisling Capital, Asset Management Company, Frazier Life Sciences, Kleiner Perkins, Longitude Capital, Lumira Ventures, Menlo Ventures, Monograph Capital Partners and 4 more.

Where is CV Therapeutics headquartered?

CV Therapeutics is headquartered in Foster City, US.

CV Therapeutics

also invests · investor profile

Foster City, US · 12 known investors

Find your way into CV Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the CV Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries. The company combines scientific rigor with global partnerships and licensing programs to expand access to medicines worldwide.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Lou LangeFounderPartner at Asset Management Company

Michael L. Riordan Founder, CEO/Chairman1987–1997

Daniel O'DayChairman and Chief Executive Officer

Investors · 12

Aisling Capitallisted by Aisling CapitalNew York

How we know: Aisling Capital's portfolio page · Not right? Tell us

Asset Management Companylisted by Asset Management CompanyMenlo Park · $500K – $2M

How we know: Asset Management Company's portfolio page · Not right? Tell us

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · Not right? Tell us

Kleiner Perkinslisted by Kleiner PerkinsMenlo Park · $500K – $15M

Longitude Capitallisted by Longitude CapitalMenlo Park · $10M – $30M

Lumira Ventureslisted by Lumira VenturesToronto · $1M – $10M

How we know: Lumira Ventures's portfolio page · Not right? Tell us

Menlo Ventureslisted by Menlo VenturesSan Francisco · $1M – $20M

How we know: Menlo Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Monograph Capital Partnerslisted by Monograph Capital PartnersLondon

New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M

Ridgeback Capitallisted by Ridgeback CapitalNew York

How we know: Ridgeback Capital's portfolio page · Not right? Tell us

RiverVest Venture Partnerslisted by RiverVest Venture PartnersSt. Louis · $500K – $3M

How we know: RiverVest Venture Partners's portfolio page · Not right? Tell us

VantagePoint Capital Partnerslisted by VantagePoint Capital PartnersSilicon Valley · $2M – $100M

Founder mafia

2 people who came through CV Therapeutics went on to found or lead other companies.

Peter CraddockBoard ObserverFounded CoinFlip Solutions EVAN SUSSMANInstitutional Cardiovascular SpecialistFounded Granata Bio

Related companies · 2

MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Johnson & JohnsonJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.

Companies working in the same space as CV Therapeutics.

Frequently asked questions

What does CV Therapeutics do?: Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries. The company combines scientific rigor with global partnerships and licensing programs to expand access to medicines worldwide.
Who founded CV Therapeutics?: CV Therapeutics was founded by Lou Lange, Michael L. Riordan.
Who are CV Therapeutics's investors?: CV Therapeutics's investors include Aisling Capital, Asset Management Company, Frazier Life Sciences, Kleiner Perkins, Longitude Capital, Lumira Ventures, Menlo Ventures, Monograph Capital Partners and 4 more.
Where is CV Therapeutics headquartered?: CV Therapeutics is headquartered in Foster City, US.